Cargando…
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer
Pain is a highly distressing symptom for patients with advanced cancer. WHO analgesic ladder is widely accepted as a guideline for its treatment. Our aim was to describe pain prevalence among patients diagnosed with advanced non-small-cell lung cancer (NSCLC), impact of pain on quality of life (QoL)...
Autores principales: | Di Maio, M, Gridelli, C, Gallo, C, Manzione, L, Brancaccio, L, Barbera, S, Robbiati, S F, Ianniello, G P, Ferraù, F, Piazza, E, Frontini, L, Rosetti, F, Carrozza, F, Bearz, A, Spatafora, M, Adamo, V, Isa, L, Iaffaioli, R V, Di Salvo, E, Perrone, F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409536/ https://www.ncbi.nlm.nih.gov/pubmed/15162156 http://dx.doi.org/10.1038/sj.bjc.6601810 |
Ejemplares similares
-
Supportive care in patients with advanced non-small-cell lung cancer
por: Di Maio, M, et al.
Publicado: (2003) -
Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses
por: Gridelli, C, et al.
Publicado: (2000) -
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study
por: Gridelli, C, et al.
Publicado: (2004) -
Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study
por: Gridelli, C, et al.
Publicado: (2001) -
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study
por: De Placido, S, et al.
Publicado: (2005)